Form 4 for COR Cencora
Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-09 · accession 0001127602-21-028992 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-12 | 2021-11-09 | COR | COLLIS STEVEN H | COB, Pres, CEO, Dir | S - Sale+OE | $125.33 | -24.3K | 184.6K | -12% | -$3.04M |
| DM | 2021-11-12 | 2021-11-09+ | COR | COLLIS STEVEN H | COB, Pres, CEO, Dir | M - OptEx | $87.53 | +37.0K | 197.4K | +23% | +$3.24M |
| D | 2021-11-12 | 2021-11-10 | COR | COLLIS STEVEN H | COB, Pres, CEO, Dir | F - Tax | $125.68 | -5,530 | 191.8K | -3% | -$695.0K |
| D | 2021-11-12 | 2021-11-10 | COR | COLLIS STEVEN H | COB, Pres, CEO, Dir | A - Grant | — | +35.8K | 35.8K | New | — |
| DM | 2021-11-12 | 2021-11-09+ | COR | COLLIS STEVEN H | COB, Pres, CEO, Dir | M - OptEx | $0.00 | -37.0K | 38.4K | -49% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-09 | S | D | 24,264 | $125.33 | 184,579 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-10 | M | A | 12,718 | — | 197,297 | D | — | — | (F1) Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2021, 11/10/2022, and 11/10/2023. |
| 3 | Common | Common Stock | 2021-11-09 | M | A | 11,480 | $75.61 | 208,843 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-10 | F | D | 5,530 | $125.68 | 191,767 | D | — | — | |
| 5 | Common | Common Stock | 2021-11-09 | M | A | 12,784 | $98.24 | 197,363 | D | — | — | |
| 6 | Derivative | Restricted Stock Units | 2021-11-10 | A | A | 35,806 | — | 35,806 | D | $0.00 · — to — | 35,806 Common Stock | (F5) Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024. |
| 7 | Derivative | Restricted Stock Units | 2021-11-10 | M | D | 12,718 | $0.00 | 25,437 | D | $0.00 · — to — | 12,718 Common Stock | (F1) Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2021, 11/10/2022, and 11/10/2023. |
| 8 | Derivative | Non-qualified Stock Option (Right to Buy) | 2021-11-09 | M | D | 11,480 | $0.00 | 172,200 | D | $75.61 · — to 2023-11-09 | 11,480 Common Stock | (F2) The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21. (F3) Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20. |
| 9 | Derivative | Non-qualified Stock Option (Right to Buy) | 2021-11-09 | M | D | 12,784 | $0.00 | 38,351 | D | $98.24 · — to 2022-11-11 | 12,784 Common Stock | (F4) Exerciseable in four equal annual installments on 11/11/16, 11/11/17, 11/11/18 and 11/11/19. |